Effectiveness of Sacubitril/Valsartan in real-life practice: experience of a single center

被引：0
|
作者：
Joana Neiva, J. N. [1 ]
Gomez-Otero, I. G. O. [2 ]
Varela-Roman, A. V. R. [2 ]
Moure Gonzalez, M. M. G. [2 ]
Seoane Blanco, A. S. B. [2 ]
Gonzalez-Juanatey, J. R. G. J. [2 ]
机构：
[1] Hosp Vila Franca Xira, Vila Franca De Xira, Portugal
[2] Univ Hosp Santiago de Compostela, Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Santiago De Compostela, Spain
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P2177
引用
收藏
页码：582 / 582
页数：1
相关论文
共 50 条
  • [1] Safety and effectiveness of sacubitril/valsartan in real-life practice
    Berger, J. Jenna
    Huynh, T.
    Nguyen, V.
    Rasti, M.
    Cyr, V.
    Giannetti, N.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 405 - 405
  • [2] Sacubitril/valsartan in real-life clinical practice
    Cavusoglu, Yuksel
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2021, 49 (05): : 353 - 356
  • [3] Tolerability and safety of Sacubitril/Valsartan in real-life practice
    Joana Neiva, J. N.
    Gomez-Otero, I. G. O.
    Varela-Roman, A. V. R.
    Moure Gonzalez, M. M. G.
    Seoane Blanco, A. S. B.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 73 - 73
  • [4] Sacubitril/Valsartan in Real-Life Practice: Experience in Patients with Advanced Heart Failure and Systematic Review
    Moliner-Abos, Carles
    Rivas-Lasarte, Mercedes
    Pamies Besora, Julia
    Fluvia-Brugues, Paula
    Sole-Gonzalez, Eduard
    Mirabet, Sonia
    Lopez Lopez, Laura
    Brossa, Vicens
    Jose Pirla, Maria
    Mesado, Nuria
    Alvarez-Garcia, Jesus
    Roig, Eulalia
    CARDIOVASCULAR DRUGS AND THERAPY, 2019, 33 (03) : 307 - 314
  • [5] Sacubitril/Valsartan in Real-Life Practice: Experience in Patients with Advanced Heart Failure and Systematic Review
    Carles Moliner-Abós
    Mercedes Rivas-Lasarte
    Julia Pamies Besora
    Paula Fluvià-Brugues
    Eduard Solé-González
    Sonia Mirabet
    Laura López López
    Vicens Brossa
    Maria José Pirla
    Nuria Mesado
    Jesús Álvarez-García
    Eulàlia Roig
    Cardiovascular Drugs and Therapy, 2019, 33 : 307 - 314
  • [6] Sacubitril/valsartan: what does the real-life experience tell us?
    Sofia Alegria, S.
    Marques, A.
    Pereira, A. R.
    Briosa, A.
    Sebaiti, D.
    Grade Santos, J.
    Repolho, D.
    Almeida, A. R.
    Simoes, O. S.
    Pereira, H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 100 - 101
  • [7] Sacubitril/valsartan reduces apneic burden in a real-life hfref population
    Sciarrone, Paolo
    Giannoni, Alberto
    Vergaro, Giuseppe
    Bramanti, Francesca
    Ludice, Giovanni
    Emdin, Michele
    Passino, Claudio
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0J) : J141 - J141
  • [8] Different response to sacubitril/valsartan in a real-life cohort of HFrEF patients
    Sciarrone, Paolo
    Giannoni, Alberto
    Vergaro, Giuseppe
    Masotti, Silvia
    Benelli, Eleonora
    Agazio, Assunta
    Clerico, Aldo
    Emdin, Michele
    Passino, Claudio
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0J) : J141 - J141
  • [9] Effectiveness and Safety of Ocrelizumab - Real-life Experience of a Tertiary Center
    Carvalho, Ines V.
    Cunha, Carolina
    Nunes, Carla
    Macario, Maria do Carmo
    Batista, Sonia
    Sousa, Livia Maria
    Correia, Ines
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1006 - 1007
  • [10] Tolerability of sacubitril/valsartan when initiating/uptitrating in real-life patients. Initial experience in two centres
    Goena Vives, C.
    Gomez Ramirez, C.
    Quintas Ovejero, L.
    Garcia Martin, R.
    Luis Serret, I.
    Natividad Andres, R.
    Sagasti Aboitiz, I.
    Campana Lazaro, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 273 - 274
12345